Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Therapy targets gram-negative bacterial infections in critical care settings Th...
Mary Bridge Children’s Hospital is preparing for the grand opening of its new st...
How much drug product loss should you expect in fill-finish? Drug product loss i...
The European Commission (EC) has approved Novartis’ Rhapsido (remibrutinib) for ...
Organon, created through a spinoff from Merck & Co (MSD) in 2021, distributes mo...
Two studies to evaluate efficacy and safety in Plasmodium falciparum and Plasmo...
Five-year agreement focuses on open science access, joint research and capabili...
Former Cipla CEO to lead next phase for CDMO platform focused on complex chemis...
The inaugural edition of FDD Conclave - Mumbai Connect, a city-focused platform...
Approval for 0.5 mg capsules therapeutically equivalent to Novartis’ Gilenya; m...
Deal combines portfolios and expands presence across women’s health, biosimilar...
Inova reached a construction milestone for its Eastern Region expansion with “to...
Under the agreement, Apotex will acquire Cumberland’s branded medicines for cash...
The initiative aims to link external scientific data with internal R&D planning ...
Agreements focus on medicine quality testing, pharmacovigilance, and pharmaceut...
Company outlines expansion across multiple states and pipeline of formulations ...
